Study guide
Secondary hypertension and arterial disease
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Secondary hypertension and arterial disease
Key Takeaways Explain This Topic AI
Hypertensive emergency involves acute target-organ injury, not an elevated reading alone.
An ankle–brachial index below 0.9 supports peripheral arterial disease.
Rest pain, ulceration or gangrene requires urgent vascular assessment.
Last updated: October 2026
Secondary Hypertension: Diagnostic Evaluation and Management
Secondary hypertension accounts for approximately 5 % to 10 % 5\%\text{ to }10\% 5% to 10% of adult hypertension. It should be investigated when clinical "red flags" appear: age of onset < 30 years < 30\text{ years} < 30 years , abrupt or severe onset, resistant hypertension (blood pressure uncontrolled despite full doses of three concurrent antihypertensives including a diuretic), or unprovoked hypokalaemia.
Clinical comparison: Secondary Hypertension Etiologies, Clinical Clues, and Investigations
Renal Parenchymal Disease : Pathophysiological Mechanism: Glomerular/tubulointerstitial loss leading to salt/water retention; Clinical Presentation & Clues: Elevated creatinine, microscopic haematuria, proteinuria; First-Line Screening Test: Urinary albumin-to-creatinine ratio (uACR), eGFR, urinalysis; Confirmatory Diagnostic Test: Renal ultrasound (bilateral small, echogenic kidneys)
Renal Artery Stenosis : Pathophysiological Mechanism: Renal hypoperfusion stimulating the renin-angiotensin cascade; Clinical Presentation & Clues: Atherosclerotic in elderly smokers; Fibromuscular Dysplasia in young females; acute creatinine rise > 30 % > 30\% > 30% post-ACEi; First-Line Screening Test: Renal duplex Doppler ultrasound; Confirmatory Diagnostic Test: CT or Magnetic Resonance Angiography ("string-of-beads" in FMD)
Primary Aldosteronism : Pathophysiological Mechanism: Autonomous adrenal aldosterone secretion suppressing renin; Clinical Presentation & Clues: Resistant hypertension; unprovoked or diuretic hypokalaemia; muscle weakness; First-Line Screening Test: Morning paired Aldosterone-to-Renin Ratio (ARR) ; Confirmatory Diagnostic Test: Saline infusion test or fludrocortisone test; adrenal CT & adrenal venous sampling
Phaeochromocytoma : Pathophysiological Mechanism: Paroxysmal catecholamine hypersecretion by chromaffin tumour; Clinical Presentation & Clues: Classic triad: episodic headaches, profuse sweating, tachycardia; First-Line Screening Test: 24-hour urinary fractionated metanephrines or plasma free metanephrines; Confirmatory Diagnostic Test: Abdominal MRI / CT; MIBG or Ga-68 DOTATATE PET scan
Hypercortisolism: Exclude exogenous glucocorticoids first. Validated initial tests include overnight low-dose dexamethasone suppression, late-night salivary cortisol or urinary free cortisol. Confirmation and localisation are separate specialist steps; high-dose dexamethasone is not an initial screening test.
Obstructive sleep apnoea: Ask about snoring, witnessed pauses, daytime sleepiness and resistant hypertension. Diagnosis uses sleep testing and clinical context; an apnoea–hypopnoea index of at least 5 with relevant symptoms can meet criteria, so 15 is not the only diagnostic threshold.
Essential Pharmacological Rule for Phaeochromocytoma
In patients with suspected or confirmed phaeochromocytoma, alpha-adrenergic blockade (e.g., phenoxybenzamine) must always precede beta-adrenergic blockade . Initiating a beta-blocker alone blocks beta-2-mediated vasodilation while leaving alpha-1-mediated vasoconstriction completely unopposed, precipitating an extreme, potentially fatal hypertensive crisis. Beta-blockers are added only after several days of effective alpha-blockade to control reflex tachycardia.
Hypertensive Emergencies vs Urgencies
Hypertensive Emergency : Severe elevation in blood pressure (typically > 180 / 120 mmHg > 180/120\text{ mmHg} > 180/120 mmHg ) associated with acute, life-threatening target organ damage :
Neurological: Hypertensive encephalopathy, acute ischaemic stroke, intracranial haemorrhage.
Cardiovascular: Acute aortic dissection, acute coronary syndrome, acute pulmonary oedema.
Renal: Acute kidney injury with haematuria and proteinuria.
Ophthalmological: Advanced Grade IV hypertensive retinopathy (papilloedema, flame haemorrhages, cotton-wool spots).
Obstetric: Severe pre-eclampsia or eclampsia.
Management : Requires admission to an intensive care or high-dependency unit, continuous intra-arterial blood pressure monitoring, and titratable intravenous agents (e.g., sodium nitroprusside, labetalol, hydralazine, glyceryl trinitrate).
The 25% Rule : Blood pressure must be lowered gradually: decrease mean arterial pressure (MAP) by no more than 20% to 25% over the first hour , and then toward 160 / 100 mmHg 160/100\text{ mmHg} 160/100 mmHg over the subsequent 2 to 6 hours. Precipitous reduction impairs autoregulation and precipitates ischaemic stroke or myocardial infarction.
Critical Exceptions to the 25% Rule :
Acute Aortic Dissection : Requires rapid reduction of SBP to < 120 mmHg < 120\text{ mmHg} < 120 mmHg and heart rate to < 60 bpm < 60\text{ bpm} < 60 bpm within 20 minutes (using IV beta-blockers such as esmolol or labetalol first, followed by vasodilators).
Acute Ischaemic Stroke : Blood pressure is not lowered unless > 220 / 120 mmHg > 220/120\text{ mmHg} > 220/120 mmHg (permissive hypertension), or > 185 / 110 mmHg > 185/110\text{ mmHg} > 185/110 mmHg if the patient is eligible for intravenous thrombolysis.
Hypertensive Urgency : Severe elevation in blood pressure without acute target organ damage. Does not require intravenous therapy or emergency hospital admission. Managed in the outpatient setting with oral agents (e.g., intensifying maintenance therapy) with blood pressure brought down safely over 24 to 48 hours. Sublingual nifedipine is strictly contraindicated due to unpredictable precipitous hypotension and associated stroke and death.
Peripheral Arterial Disease (PAD)
Peripheral arterial disease results from systemic atherosclerosis causing progressive narrowing of lower extremity arteries:
Intermittent Claudication : Exertional muscle pain, aching, or fatigue (most commonly in the calf, but may involve the thigh or buttock) that is reproducible at a fixed walking distance and resolves completely within 2 to 5 minutes of standing still.
Chronic Limb-Threatening Ischaemia (CLTI) : Severe manifestation defined by ischaemic rest pain lasting > 2 weeks > 2\text{ weeks} > 2 weeks , non-healing ulcerations, or gangrene. Rest pain is classically worse at night when recumbent due to loss of gravitational hydrostatic pressure and improves when the patient hangs the leg over the edge of the bed.
Physical Examination : Absent or diminished pulses (femoral, popliteal, posterior tibial, dorsalis pedis), femoral bruits, cool pale extremities, trophic changes (hair loss, brittle nails, shiny thin skin), and Buerger test (marked elevation pallor followed by dependent rubor due to reactive hyperaemia). Arterial ulcers are deep, painful, "punched-out" lesions with necrotic bases, typically located over pressure points (tips of toes, lateral malleolus).
Ankle-Brachial Pressure Index (ABPI) Interpretation
ABPI is calculated by dividing the highest systolic pressure measured at each ankle (dorsalis pedis or posterior tibial) by the highest brachial systolic pressure using a Doppler ultrasound probe:
ABPI: At most 0.90 supports PAD; 0.91–0.99 is borderline, 1.00–1.40 is usually normal and above 1.40 suggests incompressibility. In diabetes/CKD, toe pressures and other vascular assessment may be needed. Rest pain, ulceration and gangrene require urgent assessment regardless of a reassuring number.
Comprehensive Management
Risk Factor Modification : Absolute, complete smoking cessation (the single most potent intervention to halt limb amputation); high-intensity statin therapy (atorvastatin 80 mg 80\text{ mg} 80 mg daily); blood pressure control ( < 130 / 80 mmHg < 130/80\text{ mmHg} < 130/80 mmHg ); and tight glycaemic control.
Antiplatelet Monotherapy : Aspirin 100 mg 100\text{ mg} 100 mg daily or clopidogrel 75 mg 75\text{ mg} 75 mg daily (clopidogrel showed slight superiority in the CAPRIE trial).
Supervised Exercise Therapy (SET) : The first-line conservative intervention for claudication. Involves structured treadmill walking to near-maximal pain for 30 to 45 minutes 30\text{ to }45\text{ minutes} 30 to 45 minutes , at least 3 times weekly for a minimum of 12 weeks, which stimulates collateral circulation.
Revascularization : Indicated for patients with CLTI (rest pain, tissue loss) or severe, lifestyle-limiting claudication refractory to medical therapy. Modalities include endovascular angioplasty/stenting or surgical bypass grafting (e.g., autologous saphenous vein femoropopliteal bypass).
Primary references (checked 7 October 2026): Australian CVD risk guideline .